ArticleInflammopharmacology2023

Real life data on nintedanib safety: idiopathic pulmonary fibrosis versus systemic sclerosis-interstitial lung disease and strategies adopted to manage adverse effects.

Marco Di Battista et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.